Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation.
about
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesKallikrein-kinin in stem cell therapyCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsThe role of N-acetyltransferase 8 in mesenchymal stem cell-based therapy for liver ischemia/reperfusion injury in ratsThe regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells.Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis.Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammationBlockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation.Mesenchymal stem cell treatment for chronic renal failure.MR Imaging of Stem Cell Transplants in Arthritic Joints.Potential advantages of acute kidney injury management by mesenchymal stem cells.Mesenchymal stem cells at the intersection of cell and gene therapy.Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury.Effect of mesenchymal stem cells on renal injury in rats with severe acute pancreatitis.Maximum efficacy of mesenchymal stem cells in rat model of renal ischemia-reperfusion injury: renal artery administration with optimal numbersErythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice.Magnetic resonance imaging of stem cell apoptosis in arthritic joints with a caspase activatable contrast agent.Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke.14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury.Human amniotic fluid stem cell preconditioning improves their regenerative potential.Three-Dimensional Aggregates Enhance the Therapeutic Effects of Adipose Mesenchymal Stem Cells for Ischemia-Reperfusion Induced Kidney Injury in RatsKallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stressBreast cancer biology: the multifaceted roles of mesenchymal stem cells.Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways.Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.Selecting the optimal cell for kidney regeneration: fetal, adult or reprogrammed stem cells.Mesenchymal stem cells and kidney repair.Stem cells and their role in renal ischaemia reperfusion injury.Concise review: mesenchymal stem cell treatment for ischemic kidney diseaseMechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD.A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion.Mesenchymal Stem Cells in Kidney Repair.Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotency.Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis.Histological study on effect of mesenchymal stem cell therapy on experimental renal injury induced by ischemia/reperfusion in male albino rat.Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).Critical role of SDF-1/CXCR4 signaling pathway in stem cell homing in the deafened rat cochlea after acoustic trauma.Inducible expression of kallikrein in renal tubular cells protects mice against spontaneous lupus nephritis.Extracellular vesicles from bone marrow-derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury.
P2860
Q26799107-ED8B9FD5-BB49-4BA8-BC96-AB96D3367D56Q27010386-ABA38BCC-8B07-476C-8E07-C96CCB3A6A20Q27026350-B76A09E3-95E0-4579-96D2-AE3BBD677FB8Q28541169-D49B2AA8-DE0E-47AB-918C-F4EACD35A253Q33563134-41A7CC86-7CC0-4837-9EDC-A1AB6A0BD188Q33732799-39261EA1-36D0-4CE5-A4D8-C4281C1596CDQ33746135-4FE45774-AEF7-46EF-BCBD-2D388831D514Q33783946-6725A584-4223-4A42-AECA-DAA1A0415756Q33900483-51340DD5-D5A2-4E8B-B91D-F6C9DFE9761FQ33949771-63BEBBFA-C62C-465F-8F00-1C7154E40A60Q34259151-23D7F141-03B9-466C-B96C-F1F1096FFF58Q34676808-690803AC-E0E3-4E74-8EBF-1AE6292FA217Q34720770-E3ACA1C6-C29A-4913-8AAB-EECB725C17AFQ34897958-21745F8B-3873-4A9F-99C7-27A7DFC91550Q35122939-0C06E181-0405-490A-951E-EAE4E3B8DAA4Q35568537-1E1945D3-7B21-4372-9A10-D2841423764CQ35637325-00504CBF-FD91-43FC-A4CB-2B274ED1B09DQ35722662-FA9A2EF6-24BD-4903-A088-AC1B1C21C4E8Q35895293-219A6185-32BE-4FB8-9680-A7597565D28AQ36093158-C6CE9EC1-5E79-40E7-8323-1744825EB11CQ36329060-3F733C02-BB1F-4971-B028-3B1EB6A00609Q37039091-224F5A5A-D8B2-44F6-BBA5-DEEA0825A01CQ37111274-AC0BB019-49F0-4CAD-8ED5-50438BAD15C7Q37430751-4DF438FD-C8C3-4D19-9C40-9DE1FD934E70Q37697813-0F02A970-2067-4E12-B1C2-6D30579CDAF8Q37868851-BE9DC2AA-F4B2-40B0-9175-D227B05B3D21Q38069136-C711F848-3F0C-41BB-9B4F-33D1277D5515Q38072245-0C36A3DE-AF03-4CFB-BF31-47893387B79AQ38114399-FE6F8D04-7E9A-4E80-8A94-92B462D3B323Q38341214-695323D4-A5CB-45B0-B972-31BB477970B9Q39298233-3D523719-3A3B-436D-830F-793B15E86CB9Q39728180-3DEBB794-CB26-4827-AAB8-AB4AF9D07A56Q39766924-7A14BEB3-7070-426A-82E1-EBFDC8C40E51Q42161791-205EC343-E8C4-4515-BC3C-7042C0BC8CCAQ42867704-9BF80F26-167D-4BE7-888C-C6DE926EE767Q44279002-62E349D5-D375-4E71-ABDA-14DBF7DA5C7EQ47554530-3D59FB60-6850-444B-B92C-92032F0F3705Q49939569-55016976-3D88-4381-B7BE-419C5EFB709EQ50485658-597C8320-DF84-4791-9888-080B4C80B06AQ51060502-C6563AAD-1B15-435E-ADBF-6775D5679826
P2860
Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kallikrein-modified mesenchyma ...... ng apoptosis and inflammation.
@en
Kallikrein-modified mesenchyma ...... ng apoptosis and inflammation.
@nl
type
label
Kallikrein-modified mesenchyma ...... ng apoptosis and inflammation.
@en
Kallikrein-modified mesenchyma ...... ng apoptosis and inflammation.
@nl
prefLabel
Kallikrein-modified mesenchyma ...... ng apoptosis and inflammation.
@en
Kallikrein-modified mesenchyma ...... ng apoptosis and inflammation.
@nl
P2093
P2860
P356
P1433
P1476
Kallikrein-modified mesenchyma ...... ng apoptosis and inflammation.
@en
P2093
Julie Chao
Makoto Hagiwara
P2860
P304
P356
10.1089/HUM.2008.016
P577
2008-08-01T00:00:00Z